Topics to be addressed include molecular analysis, active surveillance of low-risk lesions, surgical management of the invaded recurrent laryngeal nerve, and use neoadjuvant targeted therapy for the treatment of advanced thyroid cancer.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1 credit
MOC types
ABOHNS — Self-AssessmentUp to 1 point
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Specialties served/covered
- Allergy & Clinical Immunology
- Diagnostic Radiology
- Facial Plastic & Reconstructive Surgery
- Foot & Ankle Surgery
- General Otolaryngology
- Head & Neck Surgery
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neuroradiology
- Otology & Neurotology
- Pediatric Otolaryngology
- Pediatric Radiology
- Rhinology
- Sleep Medicine
- ENT & Head Neck
- Medical Subspecialties
- Oncology & Hematology
- Orthopedics
- Radiology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Paid · fee on provider site
-
ReleasedDec 1, 2025
-
Last day to claim creditDec 2, 2028 2 years left
-
American Academy of Otolaryngology – Head & Neck Surgery Foundation AAO-HNS Thyroid Cancer Tumor Board (2024 AMW)
-
American Academy of Otolaryngology – Head & Neck Surgery Foundation Evidence-Based Management of Invasive Thyroid Cancer (2024 AMW)
-
American Academy of Otolaryngology – Head & Neck Surgery Foundation Advanced Thyroid Cancer Molecular Testing and Therapeutic Options (2025 AMW)
-
Learner’s Digest International (TM) Considerations for Laryngeal Complexities and Cancers
-
Physicians’ Education Resource (CME Track) Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting
-
American Society of Clinical Oncology What’s New in Rare Cancers in Head and Neck, Including Adenoid Cystic Cancer, Thyroid Cancer, and Sinus Cancers – 2026 ASCO Annual Meeting
